AstraZeneca has successfully completed the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell ...

AstraZeneca completes acquisition of biotech company, EsoBiotec: Cambridge, UK Wednesday, May 21, 2025, 09:00 Hrs [IST] AstraZeneca announced the successful completion of the acqu ...

The acquisition, initially announced in March, sees AstraZeneca pay USD425 million up front, with an additional USD575 million in potential milestone payments, bringing the total consideration to up ...

Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has ...

AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical ...

Shares of drug firm AstraZeneca are up 0.85% after the company announced that it has successfully completed the acquisition of EsoBiotec. Close Brothers shares are down more than 5% after the loan ...

Multinational pharmaceutical company AstraZeneca plc has entered into a definitive agreement to acquire the Belgian biotech company EsoBiotec. This is reported in a press release from AstraZeneca. The ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...